Portfolio company
G1 Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops and commercialises small molecule therapies to protect bone marrow in cancer patients undergoing chemotherapy.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Galera
This biopharmaceutical company develops small-molecule therapies to reduce the side effects of radiotherapy and improve treatment outcomes for patients with advanced breast cancer.
Chromacure
This company develops small molecule therapeutics for oncology patients to address unmet clinical needs in cancer treatment.
GQ Targeting
This biotechnology company develops small molecule drugs targeting G-quadruplex structures to treat patients with solid tumours.
Scorpion Therapeutics
This clinical-stage company develops small-molecule drugs and targeted therapies for patients with various forms of cancer.
Kymera Therapeutics
This biotechnology company develops small molecule medicines that degrade disease-causing proteins for patients with cancer and immune-inflammatory diseases.
SpringWorks Therapeutics
This biopharmaceutical company develops and commercialises targeted oncology medicines and therapies for patients with rare diseases and cancer.
Chimerix
This biopharmaceutical company develops medicines for oncology and viral diseases for patients with life-threatening conditions.
Athira Pharma
This biopharmaceutical company develops small molecule therapies for patients with neurodegenerative conditions and certain cancers.